1-1 of 1
Hejin Jia
Close
Sort by
Journal Articles

CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma

Yelei Guo, Chuan Tong, Liping Su, Wenying Zhang, Hejin Jia, Yang Liu, Qingming Yang, Zhiqiang Wu, Yao Wang, Weidong Han
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2695–2699.
https://doi.org/10.1182/bloodadvances.2021006232
Published: 2022
Includes: Supplemental data